Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Return on Sales [ROS] (2012 - 2026)

Updated

Phibro Animal Health's Return on Sales [ROS] was 12.83% in fiscal Q1 2027 (quarter ended Sep 30, 2026), down 1.25 percentage points from 14.09% a year earlier but up 0.70 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Phibro Animal Health's Return on Sales [ROS] was 12.51% through Sep 30, 2026, up 2.22 percentage points year-over-year; for FY2026 (ended Jun 30, 2026), it was 12.81%, up 4.28 percentage points from FY2025.

  • Return on Sales [ROS] shows a five-year change of +3.82 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Sales [ROS] was 8.52% in FY2025 (+3.28 pp), 5.24% in FY2024 (-2.11 pp), 7.35% in FY2023 (-1.04 pp) and 8.38% in FY2022 (-0.60 pp).
  • Quarterly Return on Sales [ROS] has moved between -0.31% (fiscal Q1 2024) and 14.09% (fiscal Q1 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in seven of the last eight quarters, with an average year-over-year change of +2.84 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q1 2026 (a gain of 7.29 percentage points); the worst was fiscal Q1 2024 (a drop of 6.20 percentage points).
  • Per Business Quant data, PAHC's Return on Sales [ROS] in the three fiscal quarters before Q1 2027 was 12.14% (Q4 2026), 11.64% (Q3 2026) and 13.46% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 12.83%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.83%
Jun 30, 2026 12.14%
Mar 31, 2026 11.64%
Dec 31, 2025 13.46%
Sep 30, 2025 14.09%
Jun 30, 2025 8.90%
Mar 31, 2025 9.64%
Dec 31, 2024 8.26%
Sep 30, 2024 6.80%
Jun 30, 2024 6.74%
Mar 31, 2024 7.57%
Dec 31, 2023 6.28%
Sep 30, 2023 -0.31%
Jun 30, 2023 9.32%
Mar 31, 2023 7.55%
Dec 31, 2022 6.48%
Sep 30, 2022 5.89%
Jun 30, 2022 8.97%
Mar 31, 2022 8.01%
Dec 31, 2021 9.58%
API Access

Phibro Animal Health Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PAHC&period=max&api_key=YOUR_API_KEY